DBS has strong capital buffers that allow it to weather economic downturns. As of December 2024 its common equity Tier 1 ratio was 17.0% on a transitional basis and still 15.1% even assuming final ...
Neimeth International Pharmaceuticals Plc has emerged as one of the top-performing stocks on the Nigerian Exchange (NGX) in 2025. After ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback